RS
Therapeutic Areas
Plexision Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Pleximmune | Acute cellular rejection after pediatric liver/intestine transplant | Approved |
| Pleximark | Acute cellular rejection after kidney transplantation | LDT |
| PlexABMR | Antibody-mediated rejection in transplantation | Validation |
| PlexCMV | Cellular immunity to Cytomegalovirus | LDT |
| PlexCOVID-19 | Cellular immunity to SARS-CoV-2 | LDT |
| Immuno-Oncology Service | Tumor antigenicity & anti-tumor response characterization | LDT/Service |